XML 47 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of share option plan
   
Number of options
   
Weighted average exercise
price
   
Weighted average remaining contractual life
   
Aggregate intrinsic
value
 
         
$
   
Years
   
$
 
                             
Options outstanding at beginning of year
   
8,373,745
     
4.65
     
6.61
     
1,912
 
Options granted
   
1,027,200
     
1.88
                 
Options exercised
   
(11,053
)
   
0.94
                 
Options forfeited
   
(495,781
)
   
3.33
         
Options expired
   
(238,390
)
   
7.67
                 
                                 
Options outstanding at end of year
   
8,655,721
     
4.31
     
6.05
     
802
 
                                 
Exercisable at end of year
   
5,920,552
     
5.36
     
4.93
     
286
 
Schedule Of RSUs activity
   
Number of RSUs
   
Weighted average grant date per value
 
         
$
 
               
RSUs outstanding at beginning of year
   
-
       
RSUs granted
   
319,150
     
1.70
 
RSUs forfeited
   
(1,800
)
   
1.69
 
                 
RSUs outstanding at end of year
   
317,350
     
1.70
 
Schedule of stock-based compensation expenses
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
                   
Research and development expenses
 
$
1,460
   
$
1,933
   
$
2,158
 
Marketing and business development expenses
   
115
     
(41
)
   
269
 
General and administrative expenses
   
1,448
     
1,658
     
1,901
 
                         
   
$
3,023
   
$
3,550
   
$
4,328